Yazar "Mert, Kadir Uğur" için listeleme
-
B-type natriuretic peptide in infective endocarditis
Biteker, Funda Sungur; Mert, Gurbet Özge; Mert, Kadir Uğur; Biteker, Murat (Elsevier Sci Ltd, 2015) -
Commentary: Peripartum Cardiomyopathy in Intensive Care Unit: an Update
Biteker, Murat; Mert, Kadir Uğur; Mert, Gurbet Özge (Frontiers Media Sa, 2016)We read with interest the article recently published by Dinic et al. entitled “Peripartum Cardiomyopathy in Intensive Care Unit: An Update” (1). However, we have some concerns about the article. -
Comparison of the Stroke Prevention Strategies in the Aegean Region with the Other Regions of Turkey
Doğan, Volkan; Başaran, Özcan; Biteker, Murat; Rencuzogulları, İbrahim; Mert, Kadir Uğur; Karadeniz, Fatma Özpamuk; Seyis, Sabri (Excerpta Medica Inc-Elsevier Science Inc, 2017)Epidemiological characteristics and treatment modalities of non-valvular atrial fibrillation (NVAF) may differ according to geographical distribution in Turkey. -
Cutaneous microvascular reactivity and aortic elasticity in coronary artery disease: Comparison of the laser Doppler flowmetry and echocardiography
Çekic, Edip Güvenç; Başaran, Özcan; Başaran, Nesrin Filiz; Elmas, Onur; Doğan, Volkan; Mert, Gurbet Özge; Biteker, Murat; Mert, Kadir Uğur (Academic Press Inc Elsevier Science, 2017)Background and aim: Decreased vascular reactivity in atherosclerosis was previously shown. In our study, it was aimed to demonstrate the decreased vascular functions in both microvascular and macrovascular tissues and to ... -
How Did the Updated 2019 European Society of Cardiology/European Atherosclerosis Society Risk Categorization for Patients with Diabetes Affect the Risk Perception and Lipid Goals? A Simulated Analysis of Real-life Data from EPHESUS Study
Başaran, Özcan; Doğan, Volkan; Mert, Kadir Uğur; Özlek, Bülent; Özlek, Eda; Çelik, Oğuzhan; Biteker, Murat (Turkish Society of Cardiology, 2023)Background: The recent 2019 European Society of Cardiology/European Atherosclerosis Society practice guidelines introduced a new risk categorization for patients with diabetes. We aimed to compare the implications of the ... -
Ivabradine in cardiogenic shock: Fact or fiction?
Mert, Kadir Uğur; Gurbet Mert, Özge; Altun, İbrahim; Biteker, Murat (Mosby-Elsevier, 2015)Letter to the Editor -
Kounis syndrome and antibiotics
Biteker, Funda Sungur; Doğan, Volkan; Mert, Kadir Uğur; Mert, Gurbet Ozge; Biteker, Murat (K Faisal Spec Hosp Res Centre, 2014) -
Management of LDL-cholesterol levels in patients with Diabetes Mellitus in Cardiology Practice: Real life evidence of Under-treatment from the EPHESUS registry
Mert, Kadir Uğur; Başaran, Özcan; Mert, Gurbet Özge; Doğan, Volkan; Rencüzoğulları, İbrahim; Özlek, Bülent; Cinier, Göksel; Şenol, Utku; Çelik, Oğuzhan; Özlek, Eda; Özdemir, İbrahim Halil; Özpamuk Karadeniz, Fatma; Bekar, Lütfü; Aktaş, Müjdat (Wiley, 2021)Background and aims Effective treatment of high low‐density lipoprotein cholesterol (LDL‐C) levels has been shown to improve cardiovascular outcomes of patients with diabetes mellitus (DM). Herein, we aimed to provide ... -
Management of prosthetic valve thrombosis: what is the best dosage and administration route of thrombolytics
Biteker, Murat; Başaran, Özcan; Mert, Gurbet Ozge; Doğan, Volkan; Mert, Kadir Uğur (Lippincott Williams & Wilkins, 2015) -
Prognostic relevance of left ventricle thrombus vs. ST elevation in Takotsubo syndrome
Mert, Gurbet Özge; Mert, Kadir Uğur; Biteker, Murat (Elsevier Ireland Ltd, 2018)[No abstract available] -
The reasons of poor lipid target attainment for secondary prevention in real life practice: Results from EPHESUS
Mert, Gurbet Özge; Başaran, Özcan; Mert, Kadir Uğur; Doğan, Volkan; Özlek, Bülent; Çelik, Oğuzhan; Kayıkcıoğlu, Meral (Wiley, 2019)Objective There are lack of studies considering the suboptimal management of dyslipidemia especially in cardiology outpatient clinics. This study was conducted to assess the patient adherence to cholesterol treatment ...